Bayer CropScience Ltd

Q2 FY21Fertilizers & Agrochemicals

Bayer CropScience Q2 FY21 earnings call: Revenue & Margins

Q2 FY21 investor presentation: what the company reported on revenue, margins and projects.

Price₹3,736

Market cap₹17.0K Cr

P/E23.2

Updated24 Sept 2026

Read4 min read

Based on Bayer CropScience Ltd's Q2 FY21 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year. EBITDA: Not explicitly stated for the quarter; however, for the first nine months of 2020, EBITDA before special items is €9,069 million, up +0.8% YoY (Page 5). - Operating Margin: Not directly reported for the quarter; profit before exceptional items and tax for Q2 is ₹6,098 million (Page 7).

From Bayer CropScience Ltd's Q2 FY21 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year.
Half Year (H1) Revenue: ₹26,094 million, up 14% compared to previous year.
Growth driven by early sowing, good monsoon, combined distribution strength, higher acreages, and positive commodity prices.
Crop Science sales for first nine months of 2020: €31,405 million (adjusted for currency and portfolio effects), with a slight decline of 0.1%.

2 more points management made on revenue & sales performance

Profitability & Margins

EBITDA: Not explicitly stated for the quarter; however, for the first nine months of 2020, EBITDA before special items is €9,069 million, up +0.8% YoY (Page 5).
Operating Margin: Not directly reported for the quarter; profit before exceptional items and tax for Q2 is ₹6,098 million (Page 7). The profitability ratio is around 21.9% for 2020-21 Q2, slightly above previous year (Page 7).
Profit (PAT): Specific PAT figures are not stated for the quarter.

- **Year-on-Year Change:** Revenue from operations grew +3% for Q2 and +14% for H1 YoY (Page 7). Profit before exceptional items and tax grew +23% for Q2 (Page 7). - **Margin Outlook:** No explicit margin outlook is stated in the presentation. Summary based strictly on stated figures: strong revenue and profit growth supported by better input cost management, but no explicit future margin guidance provided.

2 more points management made on profitability & margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The provided presentation does not explicitly mention any capex, capacity expansion, new plant, or project details including amounts, status, or timelines. The content focuses on: - Financial and operational performance for HY1 2020 driven by liquidation, monsoon, and sowing. - Business continuity and employee engagement during COVID-19. - Digital and smallholder initiatives, partnerships and farmer outreach.

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹211 Cr

Rev 2Mar 1

2Dharmaj Crop₹998 Cr

Rev 2Mar 2

3₹7.4K Cr

Rev 2Mar 3

4₹5.8K Cr

Rev 2Mar 3

5₹1.3K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The investor presentation does not explicitly mention any fundraising through debt or equity.
No specific references to changes in borrowings or net debt are found in the slides.
Page 9 discusses cash flow, showing higher cash flow from business operations and strong focus on collections.
Financing activities include an interim dividend payment, but no mention of new debt or equity issuance.

2 more points management made on fundraising & capital structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for Bayer CropScience Limited does not report specific details on order book, order inflow, or pending orders. Based on the content provided: - The presentation highlights strong liquidation and growth in sales, emphasizing early sowing, good monsoon, and expanded distribution. - Focus is on cash generation through collections rather than explicit order backlog figures. - There is mention of growth in Crop Protection (CP) due to early placement and supply advantages.

2 more points management made on order book & pipeline

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Bayer CropScience Ltd's management said in earlier quarters

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Bayer CropScience Ltd Q2 FY21 results?

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bayer CropScience Ltd planning capital expenditure?

The provided presentation does not explicitly mention any capex, capacity expansion, new plant, or project details including amounts, status, or timelines.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.